Camilla Sylvest
Direktor/Vorstandsmitglied bei ARGENX SE
Vermögen: 84 396 $ am 30.04.2024
Aktive Positionen von Camilla Sylvest
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01.01.2003 | - |
| Vertrieb & Marketing | 01.01.2003 | 01.01.2013 | |
| ARGENX SE | Direktor/Vorstandsmitglied | 08.09.2022 | - |
| Independent Dir/Board Member | 08.09.2022 | - | |
Novo Nordisk Pharma GmbH
 Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Corporate Officer/Principal | 18.10.2011 | - |
Danish Crown A/S
 Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - | |
| World Diabetes Foundation | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Camilla Sylvest
Ausbildung von Camilla Sylvest
| Scandinavian International Management Institute | Masters Business Admin |
| University of Southern Denmark | Graduate Degree |
Statistik
International
| Dänemark | 6 |
| Deutschland | 2 |
| Niederlande | 2 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Consumer Non-Durables | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| ARGENX SE | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Health Technology |
Danish Crown A/S
Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Consumer Non-Durables |
| World Diabetes Foundation | Miscellaneous |
- Börse
- Insiders
- Camilla Sylvest
- Erfahrung
